Abattis Announces Appointment Guy Dancosse, Q.C. to Board of Directors

Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (ATTBF) (CSE:ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that Guy Dancosse,... more →
Posted in: Press

Easton Pharmaceuticals Provides Additional Documents On Due Diligence

A specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces financing update, provides due diligence documents towards financing from a Toronto, Canada-based brokerage firm. Easton Pharmaceuticals has over the past... more →
Posted in: News

Myriad Interactive Media Inc. Quits Medical Pot Mobile App Development Project

About Myriad Interactive Media, Inc.: Myriad Interactive Media is an interactive marketing and development firm based in Toronto, Canada. Myriad designs and develops corporate websites, enterprise applications and mobile apps. Myriad has developed several in house technologies which are 100% owned and operated by Myriad Interactive... more →
Posted in: Investing